Methods for determining cancer resistance to histone deacetylase inhibitors

摘要: Described herein are methods and compositions for determining whether a particular cancer is resistant to or susceptible histone deacetylase inhibitor inhibitors. The include analysis of the expression levels at least four biomarker genes associated with response inhibitor. Also described increasing likelihood therapeutically effective treatment in patient, comprising an isolated populations nucleic acids derived from sensitive Further kits indications that optionally used conjunction aforementioned compositions.